IP Library Granted Patent US 10,279,113
Granted Patent B2
US 10,279,113 · App. 14/891,450 · Granted May 7, 2019

Needleless syringe and method for delivering therapeutic particles

Inventors: Martin Brouillette (Sherbrooke, CA); Christian Hebert (Sherbrooke, CA)
Assignee: SOCPRA SCIENCES ET GENIE S.E.C.
A61M5/3015A61M5/2053A61M2037/0007
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,279,113
App. No.
14/891,450
Granted
May 7, 2019
Kind
B2
Abstract

The present disclosure relates to a needleless syringe and method for delivering therapeutic particles. A source of therapeutic particles is located between a gas source and a cannon having a side opening. Gas released from the gas source causes a propagation of the therapeutic particles through the cannon. The side opening causes a reduction of a pressure of the gas in the cannon.

Claims (24)

1. A needleless syringe for delivering therapeutic particles, comprising:

a gas source;

a cannon having a plurality of side openings shaped as slots, the side openings being positioned along a length of the cannon and transverse to a longitudinal axis of the cannon; and

a source of therapeutic particles located between the gas source and an entrance of the cannon;

wherein:

gas released from the gas source flows in the cannon and causes a propagation of the therapeutic particles through the cannon; and

each opening of the plurality of side openings is configured to allow a portion of the gas to be expelled laterally from the cannon, causing a corresponding local reduction of a pressure of the gas in the cannon and causing a corresponding local acceleration of a flow of the gas in the cannon, so that the pressure and a velocity of the gas in the cannon gradually decrease as the gas flows beyond successive ones of the side openings.

2. The needleless syringe as defined in claim 1 , comprising a puncturable membrane for releasably sealing the gas source.

3. The needleless syringe as defined in claim 2 , comprising a gas reservoir, a valve and a driver, wherein opening of the valve releases the gas from the gas reservoir into the driver, a pressure of the gas in the driver causing a puncture of the membrane.

4. The needleless syringe as defined in claim 1 , comprising a tube surrounding the cannon, the tube having an internal diameter sufficient for allowing release of gas from the cannon through the side openings, an end of the tube opposite from the gas source forming an injection site.

5. The needleless syringe as defined in claim 4 , wherein the end of the tube opposite from the gas source extends beyond an extremity of the cannon.

6. The needleless syringe as defined in claim 1 , wherein passage of the flow of the gas along each of the side openings creates a gas expansion fan within the cannon.

7. The needleless syringe as defined in claim 1 , wherein the plurality of side openings comprise one or more groups of slots, each group comprising two or more slots positioned circumferentially at a same axial length of the cannon.

8. The needleless syringe as defined in claim 1 , wherein the plurality of side openings comprises circular slots, the cannon being supported by at least a pair of structural stiffeners connected to the cannon between the circular slots.

9. A method for delivering therapeutic particles to a skin surface, comprising:

providing a gas source;

providing a cannon having a plurality of side openings shaped as slots, the side openings being positioned along a length of the cannon and transverse to a longitudinal axis of the cannon;

placing a source of therapeutic particles between the gas source and an entrance of the cannon; and

releasing gas from the gas source to cause the gas to flow in the cannon and to cause a propagation of the therapeutic particles through the cannon;

wherein each opening of the plurality of side openings allows a portion of the gas to be expelled laterally from the cannon, causing a corresponding local reduction of a pressure of the gas in the cannon and causing a corresponding local acceleration of a flow of the gas in the cannon, so that the pressure and a velocity of the gas in the cannon gradually decrease as the gas flows beyond successive ones of the side openings.

10. The method as defined in claim 9 , wherein the gas is released at a first pressure and wherein the gas exits the cannon at a second pressure lower than the first pressure.

11. Use of the method as defined in claim 9 on a patient's skin.

12. Use of the method as defined in claim 9 in vitro.

13. Use of the method as defined in claim 9 ex vivo.

Assignments (7)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 19, 2023
From: NUGEN MEDICAL DEVICES INC.
To: SOCPRA SCIENCES ET GÉNIE S.E.C.
Reel/Frame 063377/0805 →
MERGER Recorded Apr 19, 2023
From: INOLIFE R&D INC.
To: EPG GLOBAL LTD.
Reel/Frame 063381/0584 →
MERGER Recorded Apr 19, 2023
From: EPG GLOBAL LTD.
To: NUGEN MEDICAL DEVICES INC.
Reel/Frame 063377/0390 →
CORRECTIVE ASSIGNMENT TO CORRECT THE NAME OF THE ASSIGNEE FROM INOLIFE R&C INC. TO INOLIFE R&D INC. PREVIOUSLY RECORDED ON REEL 049802 FRAME 0673. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Aug 6, 2019
From: SOCIETE DE COMMERCIALISATION DES PRODUITS DE LA RECHERCHE APPLIQUEE - SOCPRA SCIENCES ET GENIE, S.E.C. (OPERATING ALSO UNDER THE NAME SOCPRA SCIENCES ET GENIE S.E.C.)
To: INOLIFE R&D INC.
Reel/Frame 049982/0114 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 19, 2019
From: SOCIETE DE COMMERCIALISATION DES PRODUITS DE LA RECHERCHE APPLIQUEE - SOCPRA SCIENCES ET GENIE, S.E.C. (OPERATING ALSO UNDER THE NAME SOCPRA SCIENCES ET GENIE S.E.C.)
To: INOLIFE R&C INC.
Reel/Frame 049802/0673 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 18, 2015
From: BROUILLETTE, MARTIN, MR.; HEBERT, CHRISTIAN, MR.
To: UNIVERSITE DE SHERBROOKE
Reel/Frame 037067/0448 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 18, 2015
From: UNIVERSITE DE SHERBROOKE
To: SOCPRA SCIENCES ET GENIE S.E.C.
Reel/Frame 037127/0793 →
Continuity (2)
Provisional Application 61824651 · May 17, 2013
Related Publication 20160089496A1 · Mar 31, 2016